{
    "2021-04-11": [
        [
            {
                "time": "",
                "original_text": "复星医药2020年净利润增长10%，承认采购的国外疫苗存在瑕疵，已被封存！",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利润增长",
                        "疫苗",
                        "瑕疵",
                        "封存"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}